Exclusive

Publication

Byline

Location

US Patent Issued to Morinaga Milk Industry on June 16 for "Mitochondrial function-improving composition" (Japanese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,844, issued on June 16, was assigned to Morinaga Milk Industry Co. Ltd. (Tokyo). "Mitochondrial function-improving composition" was invente... Read More


US Patent Issued to PREVIWO AS on June 16 for "Method for treating and/or preventing a parasitic infection in a teleost" (Norwegian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,845, issued on June 16, was assigned to PREVIWO AS (Oslo, Norway). "Method for treating and/or preventing a parasitic infection in a teleos... Read More


US Patent Issued to B.Y.M. TECHNOLOGIES on June 16 for "Microbiome compositions" (British Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,846, issued on June 16, was assigned to B.Y.M. TECHNOLOGIES (London). "Microbiome compositions" was invented by Chiara Heide (London). Acc... Read More


US Patent Issued to Deerland Enzymes on June 16 for "Bacillus subtilis probiotics and methods of use for improving immune function, hormonal status, and physical performance" (Georgia Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,847, issued on June 16, was assigned to Deerland Enzymes Inc. (Kennesaw, Ga.). "Bacillus subtilis probiotics and methods of use for improvi... Read More


US Patent Issued to CAELUS PHARMACEUTICALS on June 16 for "Fecal matter for preventing or treating intestinal microbiome aberrations in cesarean section-born infants" (Dutch Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,848, issued on June 16, was assigned to CAELUS PHARMACEUTICALS B.V. (Zegveld, Netherlands). "Fecal matter for preventing or treating intest... Read More


US Patent Issued to QUORUM INNOVATIONS on June 16 for "Materials and methods for inhibiting a viral infection, including a coronavirus infection" (Florida Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,849, issued on June 16, was assigned to QUORUM INNOVATIONS INC. (Sarasota, Fla.). "Materials and methods for inhibiting a viral infection, ... Read More


US Patent Issued to The Trustees of the University of Pennsylvania, Novartis on June 16 for "Combination therapy using a chimeric antigen receptor" (American, Finnish Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,850, issued on June 16, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and Novartis AG (Basel, Switzerland). ... Read More


US Patent Issued to HANGZHOU CONVERD on June 16 for "Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,851, issued on June 16, was assigned to HANGZHOU CONVERD Co. LTD. (Hangzhou, China). "Isolated recombinant oncolytic adenoviruses, pharmace... Read More


US Patent Issued to Akamis Bio on June 16 for "Oncolytic adenoviruses armed with heterologous genes" (British Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,852, issued on June 16, was assigned to Akamis Bio Inc. (Cambridge, Mass.). "Oncolytic adenoviruses armed with heterologous genes" was inve... Read More


US Patent Issued to JDS Therapeutics on June 16 for "GLP-1R agonist compositions and methods of using" (New York, Connecticut Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,853, issued on June 16, was assigned to JDS Therapeutics LLC (Harrison, N.Y.). "GLP-1R agonist compositions and methods of using" was inven... Read More